Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply

by Shakur Haleema, Roberts Ian
Published 2009-12-01

Managing clinical trials

by Kenyon Sara, Farrell Barbara, Shakur Haleema
Published 2010-07-01

Use of the Oxford Handicap Scale at hospital discharge to predict Glasgow Outcome Scale at 6 months in patients with traumatic brain injury

by Shakur Haleema, Edwards Phil, Perel Pablo, Roberts Ian
Published 2008-11-01

Anti-fibrinolytic agents in post partum haemorrhage: a systematic review

by Blackhall Karen, Sydenham Emma, Roberts Ian, Ferrer Pili, Shakur Haleema
Published 2009-07-01

Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 tri...

by Ker Katharine, Kiriya Junko, Perel Pablo, Edwards Phil, Shakur Haleema, Roberts Ian
Published 2012-03-01

Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation

by Perel Pablo, Roberts Ian, Jayaraman Sudha, Cairns John, Guerriero Carla, Shakur Haleema
Published 2010-02-01

The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled t...

by Allen Elizabeth, Ronsmans Carine, Alfirevic Zarko, Gülmezoglu Metin, Elbourne Diana, Shakur Haleema, Roberts Ian
Published 2010-04-01

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

by Dewan Yashbir, Komolafe Edward O, Mejía-Mantilla Jorge H, Perel Pablo, Roberts Ian, Shakur Haleema
Published 2012-06-01

Using a business model approach and marketing techniques for recruitment to clinical trials

by Knight Rosemary, Free Caroline, Shakur Haleema, Treweek Shaun, McDonald Alison M, Speed Chris, Campbell Marion K
Published 2011-03-01

Marketing and clinical trials: a case study

by Entwistle Vikki A, Snowdon Claire, Garcia Jo, Knight Rosemary C, Shakur Haleema, Elbourne Diana R, Roberts Ian, Francis David, McDonald Alison M, Grant Adrian M, Campbell Marion K
Published 2007-11-01

European society of intensive care medicine study of therapeutic hypothermia (32-35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial)

by Stocchetti Nino, Murray Gordon D, Harris Bridget A, Mascia Luciana, Citerio Giuseppe, Polderman Kees H, Battison Claire G, Sinclair Helen, Andrews Peter JD, Menon David K, Shakur Haleema, De Backer Daniel
Published 2011-01-01

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

by Rätsep Indrek, Ravi Ramalingam R, Pachl Jan, Murillo-Cabezas Francisco, Mantilla Jorge, Hartzenberg Bennie, Frost Chris, Fletcher Olivia, Druwé Patrick, Dewan Yashbir, Quintero Juan, Boeriu Cristian, Balica Laura, Asser Toomas, Andrews Peter, Shakur Haleema, Sampaio Cristina, Singh Manmohan, Svoboda Petr, Roberts Ian
Published 2009-12-01